ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies

Nitin Kumar; Barham Abu Dayyeh; Brian J. Dunkin; Manoel Galvao Neto; Victoria Gomez; Sreenivasa Jonnalagadda; Vivek Kumbhari; Michael C. Larsen; Rahul Pannala; Marvin K. Ryou; Shelby A. Sullivan; Erik B. Wilson; Christopher C. Thompson

doi:10.1016/j.gie.2019.07.017

ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies

Nitin Kumar, Barham Abu Dayyeh, Brian J. Dunkin, Manoel Galvao Neto, Victoria Gomez, Sreenivasa Jonnalagadda, Vivek Kumbhari, Michael C. Larsen, Rahul Pannala, Marvin K. Ryou, Shelby A. Sullivan, Erik B. Wilson, Christopher C. Thompson

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1230-1233
Number of pages	4
Journal	Gastrointestinal Endoscopy
Volume	91
Issue number	6
DOIs	https://doi.org/10.1016/j.gie.2019.07.017
State	Published - Jun 2020

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Gastroenterology

Access to Document

10.1016/j.gie.2019.07.017

Cite this

Kumar, N., Dayyeh, B. A., Dunkin, B. J., Neto, M. G., Gomez, V., Jonnalagadda, S., Kumbhari, V., Larsen, M. C., Pannala, R., Ryou, M. K., Sullivan, S. A., Wilson, E. B., & Thompson, C. C. (2020). ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies. Gastrointestinal Endoscopy, 91(6), 1230-1233. https://doi.org/10.1016/j.gie.2019.07.017

@article{a2b605a7a34749ed9fb14731f5b700a2,

title = "ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies",

author = "Nitin Kumar and Dayyeh, {Barham Abu} and Dunkin, {Brian J.} and Neto, {Manoel Galvao} and Victoria Gomez and Sreenivasa Jonnalagadda and Vivek Kumbhari and Larsen, {Michael C.} and Rahul Pannala and Ryou, {Marvin K.} and Sullivan, {Shelby A.} and Wilson, {Erik B.} and Thompson, {Christopher C.}",

note = "Funding Information: DISCLOSURES: The following are the conflicts of interest disclosed at the time of submission. All authors consulted openpayments.gov. Dr Kumar was previously a consultant for Aspire Bariatrics. Dr Abu Dayyeh is a consultant for Metamodix, BFKW, DyaMx, Boston Scientific, and Medical Device Business Services; the recipient of research support from Apollo Endosurgery, USGI, Spatz Medical, GI Dynamics, Cairn Diagnostics, Aspire Bariatrics, and Medtronic; and a speaker for Johnson and Johnson, Endogastric Solutions, and Olympus. Dr Dunkin was a consultant for Boston Scientific, Ethicon, Medtronic/Covidien, and Olympus; has ownership interests in SurgWise and ORIntel; and is an advisor to and the holder of stock in ClearCam and Allotrope Medical. Dr Neto is a consultant for Fractyl, GI Dynamics, GI windows, Apollo EndoSurgery, USGI, Colubris Mx, and Keyron and a speaker for Ethicon EndoSurgery, Medtronic, and Olympus. Dr Gomez is the recipient of consulting fees from Olympus. Dr Kumbhari is a consultant for Apollo Endosurgery, Boston Scientific, Medtronic/Covidien, FuijFilm, Pentax Medical, ReShape Lifesciences, and Obalon and the recipient of research support from ERBE and Apollo Endosurgery. Dr Pannala is a consultant for HCL Technologies, the recipient of research support and general payments from Apollo Endosurgery, and the recipient of general payments from Boston Scientific, Abbvie, and Olympus. Dr Ryou is a consultant for Medtronic/Covidien, Pentax, Olympus, Fuji, Boston Scientific, EnteraSense, and GI Windows and a stockholder in GI Windows. Dr Sullivan is a consultant for Aspire Bariatrics, USGI Medical, Obalon Therapeutics, GI Dynamics, Elira, Spatz FGIA, Endo Tools Therapeutics, Phenomix Sciences, and Nitinotes; the recipient of research support from Aspire Bariatrics, Allurion, BARONova, Elira, Finch Therapeutics, Obalon Therapeutics, and ReBiotix; and the holder of stock warrants from Elira. Dr Thompson is the recipient of research support from Aspire Bariatrics, Boston Scientific and the recipient of general payments from Olympus Corporation, Boston Scientific, Spiration Inc, Covidien LP, Apollo Endosurgery, Aspire Bariatrics, Fujifilm New Development, ERBE USA, Microtech Endoscopy, Endogastric Solutions, and Olympus Latin America. The other authors disclosed no financial relationships. Funding Information: DISCLOSURES: The following are the conflicts of interest disclosed at the time of submission. All authors consulted openpayments.gov . Dr Kumar was previously a consultant for Aspire Bariatrics. Dr Abu Dayyeh is a consultant for Metamodix, BFKW, DyaMx, Boston Scientific, and Medical Device Business Services; the recipient of research support from Apollo Endosurgery, USGI, Spatz Medical, GI Dynamics, Cairn Diagnostics, Aspire Bariatrics, and Medtronic; and a speaker for Johnson and Johnson, Endogastric Solutions, and Olympus. Dr Dunkin was a consultant for Boston Scientific, Ethicon, Medtronic/Covidien, and Olympus; has ownership interests in SurgWise and ORIntel; and is an advisor to and the holder of stock in ClearCam and Allotrope Medical. Dr Neto is a consultant for Fractyl, GI Dynamics, GI windows, Apollo EndoSurgery, USGI, Colubris Mx, and Keyron and a speaker for Ethicon EndoSurgery, Medtronic, and Olympus. Dr Gomez is the recipient of consulting fees from Olympus. Dr Kumbhari is a consultant for Apollo Endosurgery, Boston Scientific, Medtronic/Covidien, FuijFilm, Pentax Medical, ReShape Lifesciences, and Obalon and the recipient of research support from ERBE and Apollo Endosurgery. Dr Pannala is a consultant for HCL Technologies, the recipient of research support and general payments from Apollo Endosurgery, and the recipient of general payments from Boston Scientific, Abbvie, and Olympus. Dr Ryou is a consultant for Medtronic/Covidien, Pentax, Olympus, Fuji, Boston Scientific, EnteraSense, and GI Windows and a stockholder in GI Windows. Dr Sullivan is a consultant for Aspire Bariatrics, USGI Medical, Obalon Therapeutics, GI Dynamics, Elira, Spatz FGIA, Endo Tools Therapeutics, Phenomix Sciences, and Nitinotes; the recipient of research support from Aspire Bariatrics, Allurion, BARONova, Elira, Finch Therapeutics, Obalon Therapeutics, and ReBiotix; and the holder of stock warrants from Elira. Dr Thompson is the recipient of research support from Aspire Bariatrics, Boston Scientific and the recipient of general payments from Olympus Corporation, Boston Scientific, Spiration Inc, Covidien LP, Apollo Endosurgery, Aspire Bariatrics, Fujifilm New Development, ERBE USA, Microtech Endoscopy, Endogastric Solutions, and Olympus Latin America. The other authors disclosed no financial relationships. ",

year = "2020",

month = jun,

doi = "10.1016/j.gie.2019.07.017",

language = "English (US)",

volume = "91",

pages = "1230--1233",

journal = "Gastrointestinal Endoscopy",

issn = "0016-5107",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies

AU - Kumar, Nitin

AU - Dayyeh, Barham Abu

AU - Dunkin, Brian J.

AU - Neto, Manoel Galvao

AU - Gomez, Victoria

AU - Jonnalagadda, Sreenivasa

AU - Kumbhari, Vivek

AU - Larsen, Michael C.

AU - Pannala, Rahul

AU - Ryou, Marvin K.

AU - Sullivan, Shelby A.

AU - Wilson, Erik B.

AU - Thompson, Christopher C.

N1 - Funding Information: DISCLOSURES: The following are the conflicts of interest disclosed at the time of submission. All authors consulted openpayments.gov. Dr Kumar was previously a consultant for Aspire Bariatrics. Dr Abu Dayyeh is a consultant for Metamodix, BFKW, DyaMx, Boston Scientific, and Medical Device Business Services; the recipient of research support from Apollo Endosurgery, USGI, Spatz Medical, GI Dynamics, Cairn Diagnostics, Aspire Bariatrics, and Medtronic; and a speaker for Johnson and Johnson, Endogastric Solutions, and Olympus. Dr Dunkin was a consultant for Boston Scientific, Ethicon, Medtronic/Covidien, and Olympus; has ownership interests in SurgWise and ORIntel; and is an advisor to and the holder of stock in ClearCam and Allotrope Medical. Dr Neto is a consultant for Fractyl, GI Dynamics, GI windows, Apollo EndoSurgery, USGI, Colubris Mx, and Keyron and a speaker for Ethicon EndoSurgery, Medtronic, and Olympus. Dr Gomez is the recipient of consulting fees from Olympus. Dr Kumbhari is a consultant for Apollo Endosurgery, Boston Scientific, Medtronic/Covidien, FuijFilm, Pentax Medical, ReShape Lifesciences, and Obalon and the recipient of research support from ERBE and Apollo Endosurgery. Dr Pannala is a consultant for HCL Technologies, the recipient of research support and general payments from Apollo Endosurgery, and the recipient of general payments from Boston Scientific, Abbvie, and Olympus. Dr Ryou is a consultant for Medtronic/Covidien, Pentax, Olympus, Fuji, Boston Scientific, EnteraSense, and GI Windows and a stockholder in GI Windows. Dr Sullivan is a consultant for Aspire Bariatrics, USGI Medical, Obalon Therapeutics, GI Dynamics, Elira, Spatz FGIA, Endo Tools Therapeutics, Phenomix Sciences, and Nitinotes; the recipient of research support from Aspire Bariatrics, Allurion, BARONova, Elira, Finch Therapeutics, Obalon Therapeutics, and ReBiotix; and the holder of stock warrants from Elira. Dr Thompson is the recipient of research support from Aspire Bariatrics, Boston Scientific and the recipient of general payments from Olympus Corporation, Boston Scientific, Spiration Inc, Covidien LP, Apollo Endosurgery, Aspire Bariatrics, Fujifilm New Development, ERBE USA, Microtech Endoscopy, Endogastric Solutions, and Olympus Latin America. The other authors disclosed no financial relationships. Funding Information: DISCLOSURES: The following are the conflicts of interest disclosed at the time of submission. All authors consulted openpayments.gov . Dr Kumar was previously a consultant for Aspire Bariatrics. Dr Abu Dayyeh is a consultant for Metamodix, BFKW, DyaMx, Boston Scientific, and Medical Device Business Services; the recipient of research support from Apollo Endosurgery, USGI, Spatz Medical, GI Dynamics, Cairn Diagnostics, Aspire Bariatrics, and Medtronic; and a speaker for Johnson and Johnson, Endogastric Solutions, and Olympus. Dr Dunkin was a consultant for Boston Scientific, Ethicon, Medtronic/Covidien, and Olympus; has ownership interests in SurgWise and ORIntel; and is an advisor to and the holder of stock in ClearCam and Allotrope Medical. Dr Neto is a consultant for Fractyl, GI Dynamics, GI windows, Apollo EndoSurgery, USGI, Colubris Mx, and Keyron and a speaker for Ethicon EndoSurgery, Medtronic, and Olympus. Dr Gomez is the recipient of consulting fees from Olympus. Dr Kumbhari is a consultant for Apollo Endosurgery, Boston Scientific, Medtronic/Covidien, FuijFilm, Pentax Medical, ReShape Lifesciences, and Obalon and the recipient of research support from ERBE and Apollo Endosurgery. Dr Pannala is a consultant for HCL Technologies, the recipient of research support and general payments from Apollo Endosurgery, and the recipient of general payments from Boston Scientific, Abbvie, and Olympus. Dr Ryou is a consultant for Medtronic/Covidien, Pentax, Olympus, Fuji, Boston Scientific, EnteraSense, and GI Windows and a stockholder in GI Windows. Dr Sullivan is a consultant for Aspire Bariatrics, USGI Medical, Obalon Therapeutics, GI Dynamics, Elira, Spatz FGIA, Endo Tools Therapeutics, Phenomix Sciences, and Nitinotes; the recipient of research support from Aspire Bariatrics, Allurion, BARONova, Elira, Finch Therapeutics, Obalon Therapeutics, and ReBiotix; and the holder of stock warrants from Elira. Dr Thompson is the recipient of research support from Aspire Bariatrics, Boston Scientific and the recipient of general payments from Olympus Corporation, Boston Scientific, Spiration Inc, Covidien LP, Apollo Endosurgery, Aspire Bariatrics, Fujifilm New Development, ERBE USA, Microtech Endoscopy, Endogastric Solutions, and Olympus Latin America. The other authors disclosed no financial relationships.

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85084528782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084528782&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2019.07.017

DO - 10.1016/j.gie.2019.07.017

M3 - Article

C2 - 31558279

AN - SCOPUS:85084528782

VL - 91

SP - 1230

EP - 1233

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 6

ER -

ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this